Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Sanofi Loses Patent Fight

September 30, 2010 7:08 am | News | Comments

A federal judge in Delaware has ruled against French drug maker Sanofi-Aventis SA in a patent dispute involving its cancer drug Taxotere.


Democrats Want FDA to Initiate Recalls

September 30, 2010 7:06 am | by Matthew Perrone | News | Comments

In spring 2009, a group of contract workers, going mostly to gas station convenience stores, bought up thousands of bottles of Motrin that had been determined to be defective but not dangerous. The workers had been hired for Johnson and Johnson, which wanted to remove the pills from the market without issuing a public recall.


Number of Medicare Plans Covering Brand Names to Triple

September 30, 2010 6:47 am | by Ricardo Alonso-Zaldivar | News | Comments

Seniors with high drug costs will soon have more options to help them cope with Medicare's prescription coverage gap. Reversing a steady decline, the number of prescription plans covering at least some brand-name drugs in the "doughnut hole" will triple next year.


Malawi Adopts UN AIDS Rules

September 30, 2010 6:45 am | News | Comments

Malawi's vice president says her AIDS-ravaged southern African country will adopt the latest U.N. health guidelines that call for putting HIV-positive people on drugs sooner.


J & J CEO to Testify to Congress

September 30, 2010 6:43 am | by Matthew Perrone | News | Comments

The chief executive of Johnson and Johnson will tell Congress his company "let the public down" with a string of quality problems that have resulted in millions of recalled medicines.


Drugs Before Surgery Reduces Odds of Mastecomy

September 30, 2010 6:40 am | by Marilynn Marchione | News | Comments

Taking hormone-blocking pills for a few months before breast cancer surgery can shrink tumors and allow many women to have just the lump removed instead of the whole breast, a new study suggests.


FDA Official Testifies Agency Too Slow

September 30, 2010 6:22 am | News | Comments

A top Food and Drug Administration official will tell Congress the agency should have acted sooner to halt a secret recall by Johnson & Johnson last year, in which the company quietly purchased defective painkillers from stores.


Identifying Multiple Routes

September 29, 2010 10:36 am | by Sarah Bacus, PhD; Chief Scientific Officer; Translational R&D Oncology; Karen J. Pry; Molecular Specialist; Assay Development Lab; Dominique Talbert, PhD; Senior Scientist; Translational R&D Oncology; Quintiles; Durham, N.C. | Articles | Comments

Multiple biomarkers and methodologies more accurately assess activation of the PI3K pathway.


A & G Receives Funding from NCI for Antibodies

September 29, 2010 8:33 am | News | Comments

A&G Pharmaceutical has received $1.2 million in Phase 2 Small Business Innovation Research funding from the National Cancer Institute to develop a neutralizing therapeutic antibody against a novel cancer-associated protein, GP88.


Tabletop Filling Station

September 29, 2010 8:22 am | Drug Discovery & Development | Product Releases | Comments

Watson-Marlow Pumps Group offers the compact Model FP50 mid-range tabletop liquid filling system as a cost-effective mid-range package filling alternative that fits between high speed automation and manual, operator-dependent filling systems.


Water Measurement

September 29, 2010 8:15 am | Product Releases | Comments

The measurement of water activity plays a decisive part in the quality inspection of humidity-sensitive products. The free water in a product influences its microbiological, chemical and enzymatic stability, and has a significant influence on the shelf life.


DynPort Wins Plague Vaccine Contract

September 29, 2010 8:06 am | News | Comments

CSC announced that the United Kingdom Ministry of Defence awarded DynPort Vaccine Company LLC, a CSC company, a contract to scope the requirements for achieving licensure of the plague vaccine in the European Union.


Mersana Appoints New CEO

September 29, 2010 8:00 am | News | Comments

Mersana Therapeutics, a platform-based cancer therapeutics company, announced that Nicholas G. Bacopoulos, Ph.D., has been appointed President and Chief Executive Officer.


Scientists Find Way to Reach Cell Nucleus

September 29, 2010 7:56 am | News | Comments

Duke University bioengineers have not only figured out a way to sneak molecular spies through the walls of individual cells, they can now slip them into the nucleus of those cells, where they can report back important information or drop off payloads.


Abatacept No Help in SLE

September 29, 2010 7:45 am | News | Comments

Results from a 12-month multi-center clinical trial did not show therapeutic benefit of abatacept over placebo in patients with non-life threatening systemic lupus erythematosus.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.